Clinical Trials
7 trialsNCT05783076 2023-08-30
SBRT Plus vNKT for Pancreatic Cancer
Changhai Hospital
Phase 2 Unknown
NCT05089266 2023-07-17
Study of αPD1-MSLN-CAR T Cells to Evaluate the Safety, Tolerability, and Effectiveness for Patients With MSLN-positive Advanced Solid Tumors
Shanghai Cell Therapy Group Co.,Ltd
Phase 1 Unknown
NCT05248048 2022-02-21
NKG2D CAR-T Cells to Treat Patients With Previously Treated Liver Metastatic Colorectal Cancer
The Third Affiliated Hospital of Guangzhou Medical University
Phase EARLY_PHASE1 Unknown
NCT04121273 2021-03-03
GPC3-targeted CAR-T Cell for Treating GPC3 Positive Advanced HCC
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 1 Unknown
NCT03638206 2019-12-11
Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies
Shenzhen BinDeBio Ltd.
Phase 1/2 Unknown
NCT03013712 2017-01-06
CARTEPC
First Affiliated Hospital of Chengdu Medical College
Phase 1/2 Unknown
NCT02959151 2016-11-08
A Study of Chimeric Antigen Receptor T Cells Combined With Interventional Therapy in Advanced Liver Malignancy
Shanghai GeneChem Co., Ltd.
Phase 1/2 Unknown